Industry Strength Score
17/100
Composite price performance score based on 3, 6, and 12-month returns, with more weight on recent trends.
ORASURE TECHNOLOGIES INC (OSUR) Stock Price & Overview
NASDAQ:OSUR • US68554V1089
Current stock price
2.95 USD
-0.09 (-2.96%)
At close:
2.95 USD
0 (0%)
After Hours:
The current stock price of OSUR is 2.95 USD. Today OSUR is down by -2.96%. In the past month the price decreased by -4.22%. In the past year, price decreased by -1.01%.
OSUR Key Statistics
52-Week Range2.08 - 3.82
Current OSUR stock price positioned within its 52-week range.
1-Month Range2.9004 - 3.27
Current OSUR stock price positioned within its 1-month range.
- Market Cap
- 203.934M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.93
- Dividend Yield
- N/A
OSUR Stock Performance
Today
-2.96%
1 Week
-1.67%
1 Month
-4.22%
3 Months
+5.73%
Longer-term
6 Months +7.66%
1 Year -1.01%
2 Years -37.63%
3 Years -41.35%
5 Years -69.30%
10 Years -61.59%
OSUR Stock Chart
OSUR Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to OSUR. When comparing the yearly performance of all stocks, OSUR turns out to be only a medium performer in the overall market: it outperformed 44.21% of all stocks.
Chartmill TA Rating
Chartmill Setup Rating
OSUR Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to OSUR. OSUR scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
OSUR Earnings
On February 25, 2026 OSUR reported an EPS of -0.27 and a revenue of 26.76M. The company missed EPS expectations (-29.12% surprise) and missed revenue expectations (-0.77% surprise).
Next Earnings DateMay 6, 2026
Last Earnings DateFeb 25, 2026
PeriodQ4 / 2025
EPS Reported-$0.27
Revenue Reported26.763M
EPS Surprise -29.12%
Revenue Surprise -0.77%
OSUR Forecast & Estimates
9 analysts have analysed OSUR and the average price target is 4.08 USD. This implies a price increase of 38.31% is expected in the next year compared to the current price of 2.95.
For the next year, analysts expect an EPS growth of 23.23% and a revenue growth 2.71% for OSUR
Analysts
Analysts80
Price Target4.08 (38.31%)
EPS Next Y23.23%
Revenue Next Year2.71%
OSUR Index Membership
OSUR is currently included in the following stock indexes tracked on ChartMill.
OSUR Financial Highlights
Over the last trailing twelve months OSUR reported a non-GAAP Earnings per Share(EPS) of -0.93. The EPS decreased by -257.69% compared to the year before.
Income Statements
Revenue(TTM)115.02M
Net Income(TTM)-68.73M
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -17.05% | ||
| ROE | -20.17% | ||
| Debt/Equity | 0 |
Chartmill High Growth Momentum
EPS Q2Q%-92.86%
Sales Q2Q%-28.53%
EPS 1Y (TTM)-257.69%
Revenue 1Y (TTM)-38.1%
OSUR Ownership
Ownership
Inst Owners89.81%
Shares69.13M
Float64.39M
Ins Owners6.52%
Short Float %5.01%
Short Ratio6.95
OSUR Industry Overview
OSUR operates in the Health Care Supplies sub-industry within the Health Care sector. This group contains 34 stocks and is scored by ChartMill on both price strength and growth momentum.
Industry Growth Score
32/100
Composite growth score based on earnings growth, revenue growth, and profitability across the sub-industry.
Relative Performance
Each rank shows how many other sub-industries were outperformed over that timeframe.
1 Month Rank
27%
Outperformed 27% of sub-industries
3 Month Rank
21%
Outperformed 21% of sub-industries
6 Month Rank
25%
Outperformed 25% of sub-industries
Industry Fundamentals & Breadth
- Members
- 34
- New Highs
- 2.9%
- New Lows
- 14.7%
- Average ROE
- 12.6%
- Average Profit Margin
- 7.8%
- Average Operating Margin
- 10.8%
- Average P/E
- 24.8
- Average Fwd P/E
- 21.6
- Average Debt/Equity
- 0.9
OSUR Competitors/Peers
The largest stocks on the US markets in the "Health Care Supplies" sub-industry
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| MDLN | MEDLINE INC-CL A | 29.84 | 58.788B | ||
| ALGN | ALIGN TECHNOLOGY INC | 14.27 | 12.814B | ||
| COO | COOPER COS INC/THE | 12.29 | 12.167B | ||
| SOLV | SOLVENTUM CORP | 10.12 | 11.554B | ||
| LNTH | LANTHEUS HOLDINGS INC | 16.14 | 5.555B | ||
| MMSI | MERIT MEDICAL SYSTEMS INC | 13.84 | 3.699B | ||
| ICUI | ICU MEDICAL INC | 14.37 | 2.97B | ||
| HAE | HAEMONETICS CORP/MASS | 11.19 | 2.754B | ||
| XRAY | DENTSPLY SIRONA INC | 8.09 | 2.359B | ||
| NEOG | NEOGEN CORP | 28.1 | 2.074B | ||
| UFPT | UFP TECHNOLOGIES INC | 19.26 | 1.496B | ||
| STAA | STAAR SURGICAL CO | N/A | 1.346B | ||
| AVNS | AVANOS MEDICAL INC | 24.15 | 1.147B |
Related stock screener links
View all stocks in the Health Care Supplies Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About OSUR
Company Profile
OraSure Technologies, Inc. engages in the development, manufacture, and distribution of point of care diagnostic tests and molecular collection devices designed to detect or diagnose critical medical conditions. The company is headquartered in Bethlehem, Pennsylvania and currently employs 500 full-time employees. The firm improves the access, quality, and value of healthcare with innovation in effortless tests and sample management solutions. The Company, together with its wholly owned subsidiaries, DNA Genotek Inc. and Sherlock Biosciences, Inc., is engaged in the development, manufacture, and distribution of rapid diagnostic tests and sample collection and stabilization devices designed to discover and detect critical medical conditions. Its portfolio of products is sold globally to clinical laboratories, hospitals, physician’s offices, clinics, public health and community-based organizations, research institutions, government agencies, pharmaceutical companies, and direct consumers. Its products and services include OraQuick ADVANCE Rapid HIV1/2 Antibody Test, OraQuick HIV Self-Test, and Diagnostics Direct Syphilis Health Check.
Company Info
IPO: 1986-11-17
ORASURE TECHNOLOGIES INC
220 E First St
Bethlehem PENNSYLVANIA 18015 US
CEO: Stephen S. Tang
Employees: 500
Phone: 13026587581
ORASURE TECHNOLOGIES INC / OSUR FAQ
What does ORASURE TECHNOLOGIES INC do?
OraSure Technologies, Inc. engages in the development, manufacture, and distribution of point of care diagnostic tests and molecular collection devices designed to detect or diagnose critical medical conditions. The company is headquartered in Bethlehem, Pennsylvania and currently employs 500 full-time employees. The firm improves the access, quality, and value of healthcare with innovation in effortless tests and sample management solutions. The Company, together with its wholly owned subsidiaries, DNA Genotek Inc. and Sherlock Biosciences, Inc., is engaged in the development, manufacture, and distribution of rapid diagnostic tests and sample collection and stabilization devices designed to discover and detect critical medical conditions. Its portfolio of products is sold globally to clinical laboratories, hospitals, physician’s offices, clinics, public health and community-based organizations, research institutions, government agencies, pharmaceutical companies, and direct consumers. Its products and services include OraQuick ADVANCE Rapid HIV1/2 Antibody Test, OraQuick HIV Self-Test, and Diagnostics Direct Syphilis Health Check.
What is the current price of OSUR stock?
The current stock price of OSUR is 2.95 USD. The price decreased by -2.96% in the last trading session.
Does OSUR stock pay dividends?
OSUR does not pay a dividend.
How is the ChartMill rating for ORASURE TECHNOLOGIES INC?
OSUR has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
On which exchange is OSUR stock listed?
OSUR stock is listed on the Nasdaq exchange.
What is the GICS sector and industry of OSUR stock?
ORASURE TECHNOLOGIES INC (OSUR) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
Can you provide the market cap for ORASURE TECHNOLOGIES INC?
ORASURE TECHNOLOGIES INC (OSUR) has a market capitalization of 203.93M USD. This makes OSUR a Micro Cap stock.